Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,820 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparison.
Hiddemann W, Aul C, Maschmeyer G, Schönrock-Nabulsi R, Ludwig WD, Bartholomäus A, Bettelheim P, Becker K, Balleisen L, Lathan B, et al. Hiddemann W, et al. Among authors: becker k. Semin Hematol. 1991 Jul;28(3 Suppl 4):35-8. Semin Hematol. 1991. PMID: 1780750 Clinical Trial. No abstract available.
High-dose versus intermediate dose cytosine arabinoside combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age adjusted randomized comparison.
Hiddemann W, Aul C, Maschmeyer G, Schönrock-Nabulsi R, Ludwig WD, Bartholomäus A, Bettelheim P, Becker K, Balleisen L, Lathan B, et al. Hiddemann W, et al. Among authors: becker k. Leuk Lymphoma. 1993;10 Suppl:133-7. doi: 10.3109/10428199309149125. Leuk Lymphoma. 1993. PMID: 8481662 Clinical Trial.
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015.
Köhne CH, De Greve J, Hartmann JT, Lang I, Vergauwe P, Becker K, Braumann D, Joosens E, Müller L, Janssens J, Bokemeyer C, Reimer P, Link H, Späth-Schwalbe E, Wilke HJ, Bleiberg H, Van Den Brande J, Debois M, Bethe U, Van Cutsem E. Köhne CH, et al. Among authors: becker k. Ann Oncol. 2008 May;19(5):920-6. doi: 10.1093/annonc/mdm544. Epub 2007 Dec 6. Ann Oncol. 2008. PMID: 18065406 Free article. Clinical Trial.
Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy).
Schilling G, Bruweleit M, Harbeck N, Thomssen C, Becker K, Hoffmann R, Villena C, Schütte M, Hossfeld DK, Bokemeyer C, de Wit M. Schilling G, et al. Among authors: becker k. Invest New Drugs. 2009 Apr;27(2):166-72. doi: 10.1007/s10637-008-9166-8. Epub 2008 Aug 12. Invest New Drugs. 2009. PMID: 18696011 Clinical Trial.
Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs. 40 Gy extended field radiotherapy alone.
Dühmke E, Diehl V, Loeffler M, Mueller RP, Ruehl U, Willich N, Georgii A, Roth S, Matthaei D, Sehlen S, Brosteanu O, Hasenclever D, Wilkowski R, Becker K. Dühmke E, et al. Among authors: becker k. Int J Radiat Oncol Biol Phys. 1996 Sep 1;36(2):305-10. doi: 10.1016/s0360-3016(96)00333-1. Int J Radiat Oncol Biol Phys. 1996. PMID: 8892452 Clinical Trial.
Link between post-stroke psychopathology and scope-of-action awareness.
Stahl B, Becker K, Kocyigit K, Denzler P, Röder P. Stahl B, et al. Among authors: becker k. Ther Adv Neurol Disord. 2024 Oct 25;17:17562864241282633. doi: 10.1177/17562864241282633. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 39494113 Free PMC article.
3,820 results